5-fluorouracil and methotrexate combination chemotherapy: The effect of drug scheduling
- 1 July 1981
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 17 (7) , 831-837
- https://doi.org/10.1016/0014-2964(81)90240-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Fluoropyrimidine-induced antagonism to free and tightly bound methotrexate: Suppression of [14C] formate incorporation into RNA and proteinPublished by Elsevier ,1980
- Schedule-dependent cytotoxicity of 5-fluorouracil and cyclophosphamide in experimental cancer chemotherapyPublished by Elsevier ,1980
- Combined effects of methotrexate and 5-fluoropyrimidine on human breast cancer cells in serum-free culturePublished by Elsevier ,1980
- Adriamycin/cyclophosphamide combination chemotherapy: The importance of drug schedulingPublished by Elsevier ,1979
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979
- Lack of vincristine-cyclophosphamide potentiation in different experimental tumour linesPublished by Elsevier ,1979
- Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapyPublished by Elsevier ,1978
- Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapyPublished by Elsevier ,1977
- Cancer Chemotherapy: An Unexpected Drug InteractionScience, 1976
- Combination chemotherapy: The interaction of methotrexate and 5-fluorouracilPublished by Elsevier ,1973